相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
Juan Montoro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
Yimei Feng et al.
FRONTIERS IN ONCOLOGY (2021)
CTLA4Ig in an Extended Schedule along with Sirolimus Improves Outcome with a Distinct Pattern of Immune Reconstitution Following Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation for Hemoglobinopathies
Sarita Rani Jaiswal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors
Tian Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study
Yimei Feng et al.
FRONTIERS IN MEDICINE (2020)
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M. Sandmaier et al.
LANCET HAEMATOLOGY (2019)
T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia
Sarita Rani Jaiswal et al.
TRANSPLANT IMMUNOLOGY (2017)
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention
F. Khimani et al.
BONE MARROW TRANSPLANTATION (2017)
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia
S. R. Jaiswal et al.
BONE MARROW TRANSPLANTATION (2015)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
Michael A. Pulsipher et al.
BLOOD (2014)
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Corey Cutler et al.
BLOOD (2014)
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
J. Labrador et al.
BONE MARROW TRANSPLANTATION (2014)
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation
Brian Kornblit et al.
HAEMATOLOGICA (2014)
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
Sepideh Shayani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
L. Johnston et al.
BONE MARROW TRANSPLANTATION (2012)
In-Stent Neoatherosclerosis A Final Common Pathway of Late Stent Failure
Seung-Jung Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
HLA-Haploidentical Stem Cell Transplantation for Hematologic Malignancies
Ephraim J. Fuchs et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors
Terzy Furlong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Epstein-Barr virus, rapamycin, and host immune responses
Sheri M. Krams et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2008)
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis
Francisco M. Marty et al.
BLOOD (2007)
FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure
Cheng Long et al.
HYPERTENSION (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
C Cutler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo
Z Hassan et al.
BONE MARROW TRANSPLANTATION (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
